Calcium antagonist therapy prevents chronic cyclosporine nephrotoxicity after renal transplantation: a prospective study.
Morales
J M
JM
Department of Nephrology, Hospital 12 de Octubre, Facultad de Medicina, Universidad Complutense de Madrid, Spain.
Andres
A
A
Rodriguez Paternina
E
E
Alcazar
J M
JM
Montoyo
C
C
Rodicio
J L
JL
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology* / Q000502:physiology; D008297:Male; D009318:Natriuresis; D009543:Nifedipine / Q000627:therapeutic use*; D011446:Prospective Studies
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D016572:Cyclosporine; D003404:Creatinine; D009543:Nifedipine